Metastatic pancreatic adenocarcinoma
Clinical trials for Metastatic pancreatic adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic pancreatic adenocarcinoma trials appear
Sign up with your email to follow new studies for Metastatic pancreatic adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug combo tested against aggressive pancreatic cancer
Disease control Not yet recruitingResearchers are testing whether combining albumin-bound paclitaxel with gemcitabine helps people with metastatic pancreatic cancer who have not yet received systemic treatment. The study enrolls about 59 adults aged 18 to 75 with confirmed metastatic pancreatic adenocarcinoma. Pa…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a Two-Drug immune attack shrink Hard-to-Treat pancreatic tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether combining two immunotherapy drugs—vilastobart and retifanlimab—can shrink tumors in people with metastatic pancreatic cancer that has a BRCA1, BRCA2, or PALB2 gene mutation. Participants receive both drugs by IV infusion over several months. …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Blood sugar control may boost chemo survival in pancreatic cancer patients
Disease control Not yet recruitingThis study looks at whether actively treating diabetes with drugs like metformin or insulin can help people with metastatic pancreatic cancer live longer when they also receive standard chemotherapy. About 210 adults with both pancreatic cancer and diabetes will be enrolled. The …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New PET tracer could light up pancreatic tumors
Diagnosis Not yet recruitingThis early-phase trial tests a new radioactive tracer (64Cu-DOTA-A2DM) for PET scans in people with advanced pancreatic cancer that has spread. The tracer is designed to attach to a protein called PSCA found on some pancreatic cancer cells, making them visible on the scan. The st…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Could a nerve zap stop cancer wasting? early trial tests device for cachexia
Symptom relief Not yet recruitingThis early-phase trial tests whether a device that blocks signals from the vagus nerve can safely help patients with metastatic pancreatic cancer who are experiencing severe weight loss (cachexia). The device is placed on the skin over the nerve and is used alongside chemotherapy…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC